Chiquita Brands International, Inc.

This long-running docket consolidates claims brought under the Alien Tort Statute and related shareholder-derivative theories against a multinational fruit company, alleging it funded a Colombian paramilitary organization responsible for human-rights abuses and murders between the late 1990s and mid-2000s, conduct the company previously admitted in a 2007 criminal plea resulting in a $25 million fine. Centralized in the Southern District of Florida in 2008, the docket carries 5 pending actions after a first bellwether trial in mid-2024 produced a unanimous jury verdict finding the company liable for $38.3 million in damages to the families of eight murder victims, a verdict the court declined to reduce and which the company has said it will appeal.

For a funder, this is a genuinely fundable, though highly specialized, mass human-rights claim: the underlying corporate conduct was already established through a prior criminal admission, and a completed bellwether trial has now produced a real, court-tested damages benchmark per plaintiff family, materially reducing the causation and general-liability uncertainty that typically makes Alien Tort Statute litigation difficult to underwrite. The remaining actions represent additional victim families whose claims can now be evaluated against that bellwether outcome, subject to the pending appeal.

Criterica Capital's commercial litigation finance line applies to remaining plaintiff families and their counsel in this docket, with pricing informed directly by the bellwether verdict and appropriately weighted for appellate risk given the company's stated intent to appeal. A structure and litigation brief on the current claim population and bellwether outcome is also available for firms evaluating remaining claims in this docket.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.